Bio Spectrum - January 2017Add to Favorites

Bio Spectrum - January 2017Add to Favorites

Magzter Gold ile Sınırsız Kullan

Tek bir abonelikle Bio Spectrum ile 8,500 + diğer dergileri ve gazeteleri okuyun   kataloğu görüntüle

1 ay $9.99

1 Yıl$99.99

$8/ay

(OR)

Sadece abone ol Bio Spectrum

1 Yıl $10.99

Kaydet 7%

bu sayıyı satın al $0.99

Hediye Bio Spectrum

7-Day No Questions Asked Refund7-Day No Questions
Asked Refund Policy

 ⓘ

Digital Subscription.Instant Access.

Dijital Abonelik
Anında erişim

Verified Secure Payment

Doğrulanmış Güvenli
Ödeme

Bu konuda

India’s leading names from the biotech industry share their views on how HR is an important aspect when it comes to Mergers and Amagztercquisitions

Meeting of Minds of Senior Management on Both Sides Is Key to Merger Success

A study of the history of mergers and acquisitions offers a broad spectrum of lessons that should be learnt, so as to ensure that such deals are successful. Be it the first wave of consolidation that occurred in the US and Europe in the 1890s or the post globalisation conglomerate behemoths that are a result of the recent wave of mergers; a key component in the success of these operations is strategic human resources planning.

Meeting of Minds of Senior Management on Both Sides Is Key to Merger Success

3 mins

Strategic HR for Today's Biotech M&As

The pharmaceutical and bio-technology sectors have been witnessing a strong trend of consolidation through mergers and acquisitions (M&A) over the last few years.

Strategic HR for Today's Biotech M&As

5 mins

Top 10 BioSpectrum Articles of 2016

In a year, BioSpectrum covers a wide array of topics from the life sciences sector which comprises among others biotechnology and allied areas, bio-pharma and pharma, healthcare and med technology etc.

Top 10 BioSpectrum Articles of 2016

4 mins

We Are Witnessing a Vibrant and Energetic Business Growth in India

The recent statistics indicate that the Indian pharmaceutical market is currently valued at USD25 billion and is expected to further grow at a CAGR of 12 per cent till 2020. India is the third largest pharmaceutical market in the world by incremental growth and seventh largest by volume, which gives a plethora of opportunities for many life sciences companies. With India’s population expected to reach 1.4 billion in 2022 (as per the 2015 UN Report on World Population), this growing population demands not only large scale production of vaccines but also research for newer vaccines relevant to India and immunotherapy. In order to meet the growing demands of the denizens of the country, Corning Life Sciences, one of the leaders in developing, manufacturing and global supplier of scientific laboratory products for over 100 years, has rolled its sleeves to achieve its goal. Outside of US, India and China are two of the biggest markets for Corning Life Sciences (CLS). In a recent conversation with BioSpectrum, Dr. Richard M. Eglen, Vice President and General Manager, Corning Life Sciences (CLS), and President, Corning International Emerging Market, revealed the expansion plans of CLS and how the company is gearing up to achieve its goal.

We Are Witnessing a Vibrant and Energetic Business Growth in India

3 mins

Bio Spectrum dergisindeki tüm hikayeleri okuyun

Bio Spectrum Magazine Description:

YayıncıMM Activ Sci-Tech Communication

kategoriBusiness

DilEnglish

SıklıkMonthly

India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.

  • cancel anytimeİstediğin Zaman İptal Et [ Taahhüt yok ]
  • digital onlySadece Dijital
BASINDA MAGZTER:Tümünü görüntüle